CA3094016C - Non-hormonal compositions and methods for male contraception - Google Patents

Non-hormonal compositions and methods for male contraception Download PDF

Info

Publication number
CA3094016C
CA3094016C CA3094016A CA3094016A CA3094016C CA 3094016 C CA3094016 C CA 3094016C CA 3094016 A CA3094016 A CA 3094016A CA 3094016 A CA3094016 A CA 3094016A CA 3094016 C CA3094016 C CA 3094016C
Authority
CA
Canada
Prior art keywords
composition
silodosin
use according
alpha
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3094016A
Other languages
English (en)
French (fr)
Other versions
CA3094016A1 (en
Inventor
Guillaume El Glaoui
Mehdi El Glaoui
Philippe Perrin
Stephane Droupy
Veronique Agathon-Meriau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmajor International
Original Assignee
Pharmajor International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmajor International filed Critical Pharmajor International
Publication of CA3094016A1 publication Critical patent/CA3094016A1/en
Application granted granted Critical
Publication of CA3094016C publication Critical patent/CA3094016C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
CA3094016A 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception Active CA3094016C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
EP18305328.9 2018-03-23
EP18305328 2018-03-23
US62/763,129 2018-03-23
PCT/EP2019/057267 WO2019180217A1 (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception

Publications (2)

Publication Number Publication Date
CA3094016A1 CA3094016A1 (en) 2019-09-26
CA3094016C true CA3094016C (en) 2023-10-10

Family

ID=65955198

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3094016A Active CA3094016C (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception

Country Status (19)

Country Link
US (3) US10912762B2 (https=)
EP (2) EP3562485B8 (https=)
JP (1) JP7270901B2 (https=)
KR (1) KR102496504B1 (https=)
CN (1) CN112074269A (https=)
AU (1) AU2019237228B2 (https=)
BR (1) BR112020018925A2 (https=)
CA (1) CA3094016C (https=)
DK (2) DK3750538T3 (https=)
ES (2) ES2989170T3 (https=)
FI (1) FI3750538T3 (https=)
IL (1) IL277372B2 (https=)
MA (1) MA53626B1 (https=)
MX (1) MX2020009937A (https=)
PL (2) PL3750538T3 (https=)
PT (1) PT3562485T (https=)
SG (1) SG11202008794TA (https=)
UA (1) UA128502C2 (https=)
WO (1) WO2019180217A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3750538T3 (pl) * 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę
AU2023384256A1 (en) * 2022-11-23 2025-03-20 Pharmajor Incorporated Modified-release silodosin compositions and use thereof in methods for male contraception

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
HUP0300128A3 (en) 2000-02-15 2004-03-29 Schering Ag Male contraceptive composition comprising norethisterone and its use
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20090186896A1 (en) * 2005-09-29 2009-07-23 Bayer Healthcare Ag PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
CN101316934A (zh) * 2005-09-29 2008-12-03 拜耳医药保健股份公司 用于治疗泌尿系统疾病的pde抑制剂及其组合
MX2009003737A (es) * 2006-10-05 2009-06-16 Panacea Biotec Ltd Composicion inyectable en deposito y su procedimiento de preparacion.
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
US20080242717A1 (en) 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
JPWO2016051782A1 (ja) 2014-09-30 2017-07-13 キッセイ薬品工業株式会社 苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
PL3750538T3 (pl) * 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę

Also Published As

Publication number Publication date
DK3750538T3 (da) 2024-09-23
EP3562485B1 (en) 2020-07-01
JP7270901B2 (ja) 2023-05-11
US11951095B2 (en) 2024-04-09
BR112020018925A2 (pt) 2020-12-29
IL277372B1 (en) 2023-05-01
MA53626B1 (fr) 2024-09-30
EP3750538B1 (en) 2024-08-14
JP2021518438A (ja) 2021-08-02
ES2813084T3 (es) 2021-03-22
IL277372A (en) 2020-11-30
PL3750538T3 (pl) 2024-11-25
US11583518B2 (en) 2023-02-21
PL3562485T3 (pl) 2020-11-16
AU2019237228A1 (en) 2020-10-01
EP3750538A1 (en) 2020-12-16
UA128502C2 (uk) 2024-07-31
US20210113526A1 (en) 2021-04-22
WO2019180217A1 (en) 2019-09-26
KR102496504B1 (ko) 2023-02-06
CA3094016A1 (en) 2019-09-26
US20230145374A1 (en) 2023-05-11
ES2989170T3 (es) 2024-11-25
PT3562485T (pt) 2020-08-27
IL277372B2 (en) 2023-09-01
CN112074269A (zh) 2020-12-11
EP3562485A1 (en) 2019-11-06
RU2020134408A (ru) 2022-04-29
FI3750538T3 (fi) 2024-09-24
MA53626A (fr) 2022-03-09
US10912762B2 (en) 2021-02-09
AU2019237228B2 (en) 2023-06-08
US20190290615A1 (en) 2019-09-26
SG11202008794TA (en) 2020-10-29
NZ767741A (en) 2024-11-29
MX2020009937A (es) 2022-09-30
RU2020134408A3 (https=) 2022-04-29
KR20200135978A (ko) 2020-12-04
DK3562485T3 (da) 2020-08-24
EP3562485B8 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
US6124337A (en) Methods and formulations for modulating the human sexual response
WO2014024193A1 (en) Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
JP2010531872A (ja) アルコール摂取症状を軽減するための方法
US11951095B2 (en) Non-hormonal compositions and methods for male contraception
MD3684344T2 (ro) Comprimate de deferipronă cu eliberare întârziată și metode de utilizare a acestora
AU749703B2 (en) Combination therapy for modulating the human sexual response
SK284937B6 (sk) Použitie prokineticky účinného antiemetika a tramadolu na výrobu liečiva na liečenie migrény
US20180125792A1 (en) Non-steroidal anti-inflammatory drugs for cough
HK40041318A (en) Non-hormonal methods for male contraception comprising (r)-silodosin
HK40041318B (en) Non-hormonal methods for male contraception comprising (r)-silodosin
RU2799756C2 (ru) Применение композиции для негормональной контрацепции и упаковка
OA21941A (en) Non-hormonal compositions and methods for male contraception.
US20240342155A1 (en) Hydroxychloroquine formulations, dosage forms, and methods of use
US20240180871A1 (en) Modified-release silodosin compositions and use thereof in methods for male contraception
WO2017100324A1 (en) Combination therapy for treating female hypoactive sexual desire disorders
US20030207891A1 (en) Combination therapy for modulating the human sexual response
EA042135B1 (ru) Таблетка деферипрона с отсроченным высвобождением и способ ее изготовления

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230224

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250311

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250311

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250311

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 7TH ANNIV.) - STANDARD

Year of fee payment: 7

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260309

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260309